Middleton & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Middleton & Co's IDXX Position: Q3 2026 in Review
Middleton & Co reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q3 2026, selling an estimated $125K and leaving 12,929 shares worth $6.75M. The position accounts for 0.72% of the portfolio, ranked #40.
Middleton & Co first reported a position in IDXX in Q2 2019 and has held it in 30 quarters since. The position peaked at $8.89M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Middleton & Co held 12,929 shares of Idexx Laboratories worth $6.75M as of Q3 2026.
- Middleton & Co sold 229 Idexx Laboratories shares in Q3 2026, an estimated $125K.
- Idexx Laboratories made up 0.72% of Middleton & Co's portfolio in Q3 2026, its #40 holding.
- Middleton & Co first reported a position in Idexx Laboratories in Q2 2019 and has held it in 30 quarters since.
- Middleton & Co's Idexx Laboratories position peaked at $8.89M in Q4 2025.
- 1,276 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Middleton & Co's 13F filing for Q3 2026, filed 23 Oct 2026.